Trial intelligence / Profile preview

DETO2X-bio: Oxygen in Suspected AMI

NCT02290080Phase 3Completed

Sponsor
Karolinska Institutet
Start
Oct 2014
Primary completion
Dec 2015
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of oxygen in acute myocardial infarction (AMI), acute coronary syndrome (ACS), sponsored by Karolinska Institutet. Started Oct 2014; status: completed.

02

Drugs

oxygen
03

Conditions

acute myocardial infarction (AMI)acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT02290080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02290080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call